132 related articles for article (PubMed ID: 25930067)
1. The role of expanded testing for Lynch syndrome in women with endometrial cancer.
Barton MK
CA Cancer J Clin; 2011; 61(5):285-6. PubMed ID: 25930067
[No Abstract] [Full Text] [Related]
2. Testing women with endometrial cancer to detect Lynch syndrome.
Kwon JS; Scott JL; Gilks CB; Daniels MS; Sun CC; Lu KH
J Clin Oncol; 2011 Jun; 29(16):2247-52. PubMed ID: 21537049
[TBL] [Abstract][Full Text] [Related]
3. Screening Families of North Texans to Identify Persons with an Increased Risk for Cancer Due to Lynch Syndrome.
Ross T; Pirzadeh-Miller S; Lahiri S; Gemmell A
Tex Med; 2019 Dec; 115(12):e1. PubMed ID: 31800088
[TBL] [Abstract][Full Text] [Related]
4. Lynch Syndrome and Endometrial Cancer.
Singh S; Resnick KE
South Med J; 2017 Apr; 110(4):265-269. PubMed ID: 28376523
[TBL] [Abstract][Full Text] [Related]
5. Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes: A Focus on Lynch Syndrome and Associated Endometrial Cancer.
Tafe LJ
J Mol Diagn; 2015 Sep; 17(5):472-82. PubMed ID: 26162329
[TBL] [Abstract][Full Text] [Related]
6. Genetic counseling and cascade genetic testing in Lynch syndrome.
Hampel H
Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
[TBL] [Abstract][Full Text] [Related]
7. Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease.
Taylor N; Mutch DG
Oncology (Williston Park); 2006 Jan; 20(1):85-94; discussion 94-6, 100. PubMed ID: 16572595
[TBL] [Abstract][Full Text] [Related]
8. Should women with Lynch syndrome be offered gynaecological cancer surveillance?
Ryan N; Snowsill T; McKenzie E; Monahan KJ; Nebgen D
BMJ; 2021 Sep; 374():n2020. PubMed ID: 34475027
[No Abstract] [Full Text] [Related]
9. Endometrial cancer in four sisters: report of a kindred with presumed cancer family syndrome.
Menko FH; Verheijen RH; Everhardt E; Louwé LA; Wijnen JT; Band SC; Felt-Bersma RJ; Vasen HF; Khan PM
Gynecol Oncol; 1994 Aug; 54(2):171-4. PubMed ID: 8063241
[TBL] [Abstract][Full Text] [Related]
10. Women with HNPCC: a target population for the chemoprevention of gynecologic cancers.
Broaddus RR; Lu KH
Front Biosci; 2006 Sep; 11():2077-80. PubMed ID: 16720294
[TBL] [Abstract][Full Text] [Related]
11. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
[TBL] [Abstract][Full Text] [Related]
12. Clinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial Cancer.
Bruegl AS; Ring KL; Daniels M; Fellman BM; Urbauer DL; Broaddus RR
Cancer Prev Res (Phila); 2017 Feb; 10(2):108-115. PubMed ID: 27965287
[TBL] [Abstract][Full Text] [Related]
13. Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome.
Hadley DW; Jenkins JF; Steinberg SM; Liewehr D; Moller S; Martin JC; Calzone KA; Soballe PW; Kirsch IR
J Clin Oncol; 2008 Feb; 26(6):948-54. PubMed ID: 18281669
[TBL] [Abstract][Full Text] [Related]
14. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of endometrial cancer in Lynch syndrome: a step forward.
Stoffel EM; Walsh C
Cancer Prev Res (Phila); 2013 Aug; 6(8):755-9. PubMed ID: 23842794
[TBL] [Abstract][Full Text] [Related]
16. Lynch syndrome: five unanswered questions.
Castellsagué E; Foulkes WD
Clin Genet; 2015 Jun; 87(6):503-6. PubMed ID: 25737380
[No Abstract] [Full Text] [Related]
17. Mismatch repair deficiency testing in clinical practice.
Buza N; Ziai J; Hui P
Expert Rev Mol Diagn; 2016; 16(5):591-604. PubMed ID: 26895074
[TBL] [Abstract][Full Text] [Related]
18. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
Lu KH; Dinh M; Kohlmann W; Watson P; Green J; Syngal S; Bandipalliam P; Chen LM; Allen B; Conrad P; Terdiman J; Sun C; Daniels M; Burke T; Gershenson DM; Lynch H; Lynch P; Broaddus RR
Obstet Gynecol; 2005 Mar; 105(3):569-74. PubMed ID: 15738026
[TBL] [Abstract][Full Text] [Related]
19. Contribution of ultrasonography to endometrial cancer screening in patients with hereditary nonpolyposis colorectal cancer/Lynch syndrome.
Lécuru F; Huchon C; Metzger U; Bats AS; Le Frère Belda MA; Olschwang S; Puig PL
Int J Gynecol Cancer; 2010 May; 20(4):583-7. PubMed ID: 20686377
[TBL] [Abstract][Full Text] [Related]
20. Gynecologic Cancers in Lynch Syndrome/HNPCC.
Lu KH; Broaddus RR
Fam Cancer; 2005; 4(3):249-54. PubMed ID: 16136386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
